SG156668A1 - Angiopoietin-2 specific binding agents - Google Patents

Angiopoietin-2 specific binding agents

Info

Publication number
SG156668A1
SG156668A1 SG200907008-7A SG2009070087A SG156668A1 SG 156668 A1 SG156668 A1 SG 156668A1 SG 2009070087 A SG2009070087 A SG 2009070087A SG 156668 A1 SG156668 A1 SG 156668A1
Authority
SG
Singapore
Prior art keywords
angiopoietin
specific binding
binding agents
antibodies
disclosed
Prior art date
Application number
SG200907008-7A
Other languages
English (en)
Inventor
Jonathon Daniel Oliner
Kevin Graham
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/982,440 external-priority patent/US7658924B2/en
Application filed by Amgen Inc filed Critical Amgen Inc
Publication of SG156668A1 publication Critical patent/SG156668A1/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG200907008-7A 2004-10-19 2005-10-19 Angiopoietin-2 specific binding agents SG156668A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62016104P 2004-10-19 2004-10-19
US10/982,440 US7658924B2 (en) 2001-10-11 2004-11-04 Angiopoietin-2 specific binding agents

Publications (1)

Publication Number Publication Date
SG156668A1 true SG156668A1 (en) 2009-11-26

Family

ID=39608222

Family Applications (1)

Application Number Title Priority Date Filing Date
SG200907008-7A SG156668A1 (en) 2004-10-19 2005-10-19 Angiopoietin-2 specific binding agents

Country Status (10)

Country Link
JP (2) JP2008520188A (ru)
CN (1) CN101495513B (ru)
BR (1) BRPI0518209A (ru)
EA (1) EA011866B1 (ru)
IL (1) IL182279A0 (ru)
MA (1) MA29015B1 (ru)
MX (1) MX2007004247A (ru)
RU (2) RU2404992C2 (ru)
SG (1) SG156668A1 (ru)
ZA (1) ZA200704020B (ru)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008520188A (ja) * 2004-10-19 2008-06-19 アムジエン・インコーポレーテツド アンジオポエチン−２特異的結合物質
JO3182B1 (ar) * 2009-07-29 2018-03-08 Regeneron Pharma مضادات حيوية بشرية عالية الالفة مع تولد الاوعية البشرية - 2
EA022546B1 (ru) * 2011-09-28 2016-01-29 Федеральное Государственное Бюджетное Учреждение Науки Институт Биоорганической Химии Им. Академиков М.М. Шемякина И Ю.А. Овчинникова Российской Академии Наук Способ торможения роста карциномы эрлиха у лабораторного животного
JP2014532053A (ja) * 2011-09-30 2014-12-04 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド 治療用ペプチド
WO2013112438A1 (en) * 2012-01-23 2013-08-01 Regeneron Pharmaceuticals, Inc. Stabilized formulations containing anti-ang2 antibodies
WO2014100834A1 (en) * 2012-12-21 2014-06-26 The Regents Of The University Of California Methods and compositions for treatment of cyanide and hydrogen sulfide toxicity
MX368099B (es) * 2013-05-14 2019-09-19 Eisai R&D Man Co Ltd Biomarcadores para predecir y evaluar el grado de respuesta de sujetos con cancer de endometrio a compuestos de tipo lenvatinib.
AR100270A1 (es) * 2014-05-19 2016-09-21 Lilly Co Eli Anticuerpos ang2
KR102329681B1 (ko) 2014-08-28 2021-11-23 에자이 알앤드디 매니지먼트 가부시키가이샤 고순도의 퀴놀린 유도체 및 이를 제조하는 방법
BR112017017428A2 (pt) 2015-02-25 2018-04-03 Eisai R&D Management Co., Ltd. ?método para supressão do amargor de derivado de quinolina?
CA2978226A1 (en) 2015-03-04 2016-09-09 Merck Sharpe & Dohme Corp. Combination of a pd-1 antagonist and a vegfr/fgfr/ret tyrosine kinase inhibitor for treating cancer
BR112017027227B1 (pt) 2015-06-16 2023-12-12 Eisai R&D Management Co., Ltd Agente anti-câncer
CN106075448A (zh) * 2016-07-25 2016-11-09 广州道瑞医药科技有限公司 Angpt2抑制剂在制备用于治疗血管瘤的药物中的应用
CN106512006A (zh) * 2016-07-25 2017-03-22 广州道瑞医药科技有限公司 Angpt2分泌抑制剂在制备用于治疗血管瘤的药物中的应用
CN109096368B (zh) * 2018-09-30 2021-07-20 华南理工大学 一种同时具有抗氧化和护肝活性的多肽及编码该多肽的基因与其制备方法和应用
KR102527315B1 (ko) * 2019-02-25 2023-05-03 주식회사 파멥신 항-Ang2 항체 및 이의 용도
CN112126671B (zh) * 2020-08-18 2021-08-31 中山大学附属第五医院 无乳链球菌Streptococus agalactiae治疗子宫内膜异位症的应用
CN116265487A (zh) * 2021-12-16 2023-06-20 三优生物医药(上海)有限公司 抗ang2-vegf双特异性抗体及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002540165A (ja) * 1999-03-26 2002-11-26 リジェネロン・ファーマシューティカルズ・インコーポレイテッド Ｔｉｅ２レセプターアクチベーターによる血管透過性の調節
US7205275B2 (en) * 2001-10-11 2007-04-17 Amgen Inc. Methods of treatment using specific binding agents of human angiopoietin-2
US7521053B2 (en) * 2001-10-11 2009-04-21 Amgen Inc. Angiopoietin-2 specific binding agents
CA2473970C (en) * 2001-10-12 2013-05-28 Monosolrx Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
JP2008520188A (ja) * 2004-10-19 2008-06-19 アムジエン・インコーポレーテツド アンジオポエチン−２特異的結合物質

Also Published As

Publication number Publication date
RU2007118670A (ru) 2008-12-27
CN101495513B (zh) 2014-08-06
EA011866B1 (ru) 2009-06-30
MA29015B1 (fr) 2007-11-01
CN101495513A (zh) 2009-07-29
JP2008520188A (ja) 2008-06-19
IL182279A0 (en) 2007-07-24
ZA200704020B (en) 2008-06-25
JP2011207882A (ja) 2011-10-20
MX2007004247A (es) 2007-06-12
BRPI0518209A (pt) 2008-11-04
RU2404992C2 (ru) 2010-11-27
RU2010132956A (ru) 2012-02-10
EA200700876A1 (ru) 2007-10-26

Similar Documents

Publication Publication Date Title
SG156668A1 (en) Angiopoietin-2 specific binding agents
RS28904A (en) Angiopoietin-2 specific binding agents
MY156458A (en) Antibodies directed to angiopoietin-1 and angiopoietin-2 and uses thereof
LUC00025I1 (ru)
SG166090A1 (en) Il-13 binding agents
WO2010017103A3 (en) Fully human anti-human nkg2d monoclonal antibodies
EA200400526A1 (ru) Агенты, специфически связывающиеся с человеческим ангиопоэтином-2
PH12016500658A1 (en) Human anti-alpha-synuclein autoantibodies
WO2012047583A3 (en) Antibodies binding human collagen ii
WO2010136311A3 (en) Compositions and methods for antibodies targeting complement protein c3b
WO2006029219A3 (en) Human monoclonal anti-ctla4 antibodies in cancer treatment
UA94211C2 (ru) Выделенное полностью человеческое моноклональное cd3 антитело
WO2006029220A3 (en) Combination therapy with anti-ctla4 and anti-4-1bb antibodies
WO2006116319A3 (en) Reagents that bind ccx-ckr2
WO2007076465A3 (en) Cln248 antibody compositions and methods of use
WO2006013462A3 (en) Growth factors nsg28, nsg30, and nsg32
TN2010000374A1 (en) Antibodies directed to angiopoietin -1 and angiopoietin-2 and use thereof
MX360580B (es) Autoanticuerpos humanos anti-alfa-sinucleina.